Alexander Falkentoft

MD, PhD student, interested in cardiology and diabetes.

[M. El-Chouli @m_chouli]

Ever wonder about all the non-cardiovascular diseases in #MI patients? Read this amazing paper on temporal trends on non-CV disease in MI patients through 17 years by @DanielMolager and @tsg_sehested in @JACCJournals.

#CardioTwitter #NonCardiotwitter

[Dept. of Cardiology, Zealand University Hospital @CardiologyZuh]

Many relevant findings from PhD student @kasperbengtsen in his national study on risk factors associated with early and late S. aureus bacteraemia in CIED pts presented at #ESCCongress 🫀🧫

Congratulations on the hard work!👏👏

#ESC2023 #DCS_ESC23

[Alexander Falkentoft @AFalkentoft]

Our new study demonstrates higher risk of MACE in ppl achieving initial remission of T2D. More attention to RF management with statins and RASi seems needed in lifestyle-treated individuals without glucose-lowering therapy. @CardiologyZuh @ARuwald @bochrajamal

[Diabetologia @DiabetologiaJnl]

Danish data show higher CV risk in individuals with initial remission of #T2D than in those with well-controlled T2D on glucose-lowering therapy. This appeared related to lower CV RF management with statins and RASi. @AFalkentoft @ARuwald @Filip_Knop https://t.co/j5wPhLtNZX 🔓

[Daniel J Drucker @DanielJDrucker]

Beyond glucose control, the opportunity for risk factor management in PPL with new #T2D often remains unfulfilled leading to higher rates of #heartdisease #CVD @Filip_Knop @DiabetologiaJnl https://t.co/HF2sKXHh7E

[Tour de France™ @LeTour]

🔁 RT if you think 🇩🇰 @Mads__Pedersen is the Super-combative of the #TDF2023!

🔁 RT si vous pensez que 🇩🇰 @Mads__Pedersen est le Super-combatif du #TDF2023 !

[Jarl Emanuel Strange @JarlStrange]

What is the association between #frailty and time in hospital following #TAVR? Find out in @JAHA_AHA

Frail patients have an⬆️risk of death & complications. For these patients, life-expectancy is limited and time in hospital is central for quality of life, yet data remain sparse

[Copenhagen Cardiovascular Research Center @CopCard]

In this @TheLancet sdy @MariamElmegaard et al found that in 77,745 ptts w first time SGLT2-is and 56,037 GLP1-RAs the risk of discontinuing was 56% and 45%, respectively, w a decreased risk over the sdy-period

https://t.co/zJWKje8tpy

#Cardiotwitter @cardiology @diabetes

[Filip K. Knop @Filip_Knop]

Data on all Danish first-time users of SGLT2is and GLP1-RAs from 2013 to 2021 show that ~50% discontinued therapy within five years, but a quarter of these reinitiated therapy during the following year.
Discontinuation rates decreasing with time.
https://t.co/DRY2zdHmYC

[David Laursen @LaursenDavid]

🧵 In our recent #Cochrane Review, we look at the impact of using #ActivePlacebo control versus standard placebo in randomised drug trials.

https://t.co/7VwTOSRKxF

#Blinding #Unblinding #Placebo #Bias @cochranemthds @AsgerPaludan @ChrisPaWer

1/10

[Dept. of Cardiology, Zealand University Hospital @CardiologyZuh]

In this sdy, @cnsolli et al. found that 1 dose of amoxicillin/clavulanic acid 500/125 mg or clindamycin 600 mg within 30-120 min. prior to hemodialysis was sufficient to maintain prophylactic plasma concentrations throughout the whole duration.

🦠+💊=💀

https://t.co/aDwPK1zhfa

[M. El-Chouli @m_chouli]

Just out in @ESC_journals: Simple CHD💔patients faced ⬆️ lifetime risk of comorbidity i.a. #AF #mi #stroke & #heartfailure compared w controls, manifested in ⬆️ age 👴🏼🧓🏼. https://t.co/fN7ikB6Jt9

#ACHD #CVD #cardiotwitter @escardio @Hjerteforening @CopCard @ehj_ed

[Copenhagen Cardiovascular Research Center @CopCard]

Improved outcomes after MI over time 📈

2️⃣0️⃣0️⃣0️⃣🆚2️⃣0️⃣1️⃣7️⃣
☠️Mortality, 18.6% to 12.5%
💔Recurrent MI, 7.5% to 5.5%
🩸Bleeding, 3.9% to 2.7%

Mortality was as low as 2.6% in 2015–17 for pts <60 years 👀

https://t.co/VW26roGqju

#CardioTwitter #Cardiology

[EHJ Editor-in-Chief @ehj_ed]

Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study
@escardio @ESC_Journals #CardioTwitter #EHJ #myocardialinfarction
https://t.co/8QqhgkvZY4

[Jarl Emanuel Strange @JarlStrange]

Important contribution to the growing field of cardio-oncology.
How does cancer type & status impact the prognosis of ACS? What is the cause of death? How are they managed? All important questions addressed by @NinaNouhravesh
Find out below!
https://t.co/AhLqMSd7fS

[Copenhagen Cardiovascular Research Center @CopCard]

Cardiovascular disease was the leading cause of death in pts w active- and non-active cancers 🦀

Sdy from @NinaNouhravesh et al in @AmericanHeartJ
👇
https://t.co/DIw8XsTZKv

[Copenhagen Cardiovascular Research Center @CopCard]

In this @ESC_Journals #QCCO sdy @PaulineRavn et al found decreasing ⬇️ risk of recurrent #myocardial_infarction, first-time admission 🏥 for #heartfailure and all-cause mortality 💀 in patients with a first-time myocardial infarction

🔗https://t.co/P5nTXbdRRF

[Alexander Falkentoft @AFalkentoft]

@DanielMolager @BojerStege @CopCard @CardiologyZuh @cardio_dk Thank you for your interest. No we have not published the paper yet. The abstract is available at the ESC website https://t.co/CRUjpvGPRP

[Copenhagen Cardiovascular Research Center @CopCard]

In this #EHJQCCO sdy @DanielMolager et al found influenza vaccine 💉 uptake is suboptimal among ptts w CVD, even w free-of-charge vaccinations 🧬

Vaccine uptake was particularly low among young patients 👦🏼👧🏾🧒🏽

🔗https://t.co/yzwuDgCozd

#cardiotwitter #Cardiology

[Dept. of Cardiology, Zealand University Hospital @CardiologyZuh]

This @IJCardio sdy by @cnsolli found that pts w/ myeloproliferative neoplasms in a DK cohort had ⬆️frequency of aortic valve and severe coronary artery calcifications than general pts.

https://t.co/0wYP8DKrWH

#cardiotwitter #atherosclerosis #dkforsk #hematology #mpn #mpnsm

[Copenhagen Cardiovascular Research Center @CopCard]

In this @AnnalsofIM sdy @AndersHolt6 et al found that from 2000 to 2018, the use of PDE5 inhibitors🍆 increased 2️⃣0️⃣-fold among ptts with IHD who were taking nitrates

No significant increased 🛑of CV events were found in these ptts

🔗https://t.co/aOJT4bhfS4

#CardioTwitter